Peter Libby and Team Reveal Causal Proteomic Links in Clonal Hematopoiesis
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Women’s Hospital, posted on LinkedIn:
”Causal Proteomic Consequences of Clonal Hematopoiesis: Integrated Human Genetic and Murine Validation
Zhi Yu, Amelie Vromman…Art Schuermans…Thiago Rentz Ferreira Laginski… Abhishek Niroula…Michael C. Honigberg, Amy E. Lin …Sara Haidermota…Benjamin Ebert…Alexander G. Bick, Siddhartha Jaiswal, Robert E. Gerszten, Peter Libby, Rajat Gupta, Pradeep Natarajan
Presented elegantly today at AHA New Orleans by Zhi Yu, the results of an amazing collaboration on CHIP proteomics that provide new insights and generate novel mechanistic hypotheses regarding the manifold clinical consequences of this newly recognized risk factor.”
Stay updated with Hemostasis Today.
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards
-
Feb 25, 2026, 15:09Wolfgang Miesbach: Efficacy, Safety and Thrombosis Signals in Haemophilia A/B with Inhibitors